RAPPORT THERAPEUTICS INC (RAPP) Stock Analyst Earnings Estimates
NASDAQ:RAPP - Nasdaq - US75383L1026 - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||
| EBITDA YoY % growth | -10.352M | -36.067M -248.41% | N/A -144.28% | N/A -62.69% | N/A -29.83% | |
| EBIT YoY % growth | -10.367M | -36.179M -248.98% | N/A -139.32% | N/A -58.24% | N/A -34.06% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 11.55% | N/A -21.59% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.64 | -0.73 | -0.81 52.40% | -0.85 -70.68% | -1.00 -56.27% | -0.98 -34.58% | -0.97 -19.75% | -1.24 -45.82% | -1.28 -27.99% |
| Revenue Q2Q % growth | |||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -25.439M 29.69% | -28.348M -65.83% | -31.436M -51.14% | -35.353M -63.37% | -40.269M -58.30% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.50 | -0.59 | 0.09 | 14.90% |
| Q2 2024 Q2Q % growth | -1.70 | -0.69 | -1.01 | -146.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |